2hdm
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2hdm.jpg|left|200px]] | [[Image:2hdm.jpg|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2hdm", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | + | --> | |
| - | + | {{STRUCTURE_2hdm| PDB=2hdm | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Solution structure of V21C/V59C Lymphotactin/XCL1''' | '''Solution structure of V21C/V59C Lymphotactin/XCL1''' | ||
| Line 29: | Line 26: | ||
[[Category: Tuinstra, R L.]] | [[Category: Tuinstra, R L.]] | ||
[[Category: Volkman, B F.]] | [[Category: Volkman, B F.]] | ||
| - | [[Category: | + | [[Category: Chemokine]] |
| - | [[Category: | + | [[Category: Conformational restriction]] |
| - | [[Category: | + | [[Category: Lymphotactin]] |
| - | [[Category: | + | [[Category: Nmr]] |
| - | [[Category: | + | [[Category: Xcl1]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 06:09:28 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 03:09, 4 May 2008
Solution structure of V21C/V59C Lymphotactin/XCL1
Overview
Chemokines adopt a conserved tertiary structure stabilized by two disulfide bridges and direct the migration of leukocytes. Lymphotactin (Ltn) is a unique chemokine in that it contains only one disulfide and exhibits large-scale structural heterogeneity. Under physiological solution conditions (37 degrees C and 150 mM NaCl), Ltn is in equilibrium between the canonical chemokine fold (Ltn10) and a distinct four-stranded beta-sheet (Ltn40). Consequently, it has not been possible to address the biological significance of each structural species independently. To stabilize the Ltn10 structure in a manner independent of specific solution conditions, Ltn variants containing a second disulfide bridge were designed. Placement of the new cysteines was based on a sequence alignment of Ltn with either the first (Ltn-CC1) or third disulfide (Ltn-CC3) in the CC chemokine, HCC-2. NMR data demonstrate that both CC1 and CC3 retain the Ltn10 chemokine structure and no longer exhibit structural rearrangement. The ability of each mutant to activate the Ltn receptor, XCR1, has been tested using an intracellular Ca2+ flux assay. These data support the conclusion that the chemokine fold of Ltn10 is responsible for receptor activation. We also examined the role of amino- and carboxyl-terminal residues in Ltn-mediated receptor activation. In contrast to previous reports, we find that the 25 residues comprising the novel C-terminal extension do not participate in receptor activation, while the native N-terminus is absolutely required for Ltn function.
About this Structure
2HDM is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity., Tuinstra RL, Peterson FC, Elgin ES, Pelzek AJ, Volkman BF, Biochemistry. 2007 Mar 13;46(10):2564-73. Epub 2007 Feb 16. PMID:17302442 Page seeded by OCA on Sun May 4 06:09:28 2008
